Disclosure Panels Details Page
Central Nervous System Cancers Panel - Disclosures as of 02/05/2016
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Mario Ammirati MD, MBA | None | None | None | None | - |
| Joachim Baehring MD | Bristol Myers Squibb | Novartis Pharmaceuticals Corporation | Merck & Co., Inc. | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Henry Brem MD | Johns Hopkins University | AsclepiX Therapeutics Celsion-EGEN Perosphere Inc. StemGen |
None | None | - |
| Paul Brown MD | National Cancer Institute | Novocure | None | None | - |
| Jennifer Burns BS | None | None | None | None | - |
| Nicholas Butowski MD | None | Roche Laboratories, Inc. | Genentech, Inc. | None | - |
| Marc Chamberlain MD | NCCN Funded Bendamustine trial for Recurrent High-Grade Gliomas | Novartis Advisory Board | Nativis Neonc Inc |
None | - |
| Anita Engh PhD | None | None | None | None | - |
| Robert Fenstermaker MD | Celgene Corporation MimiVax |
None | None | MimiVax | - |
| Fayna Ferkle PharmD | None | None | None | None | - |
| Peter Forsyth MD | None | None | None | None | - |
| Allan Friedman MD | None | None | None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Jona Hattangadi-Gluth MD | None | None | None | None | - |
| Matthias Holdhoff MD, PhD | None | None | Cavion | None | - |
| Larry Junck MD | Celldex Northwest Biotherapeutics, Inc. Novocure, Inc. Tocagen, Inc. |
Abbott Laboratories | None | None | - |
| Thomas Kaley MD | None | None | None | None | - |
| Jay Loeffler MD | None | None | None | None | - |
| Joan McClure MS | None | None | None | None | - |
| Nicole McMillian MS | None | None | None | None | - |
| Paul Moots MD | ECOG | None | None | None | - |
| Maciej Mrugala MD, PhD, MPH | None | Novocure Prime Oncology |
None | None | - |
| Louis Nabors MD | Abbott Laboratories Boehringer Ingelheim GmbH Cavion Cortice Biosciences Eli Lilly and Company Genentech, Inc. GSK Univ Penn Ziopharm |
None | None | None | - |
| Seema Nagpal MD | Nektar Therapeutics Regeneron Tocagen ZioPharm |
Nektar Therapuetics Novartis Pharmaceuticals Corporation Regeneron |
Novocure | None | - |
| Ian Parney MD, PhD | None | None | None | None | - |
| Jana Portnow MD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| John Ragsdale III MD | NA | NA | NA | NA | - |
| Lisa Rogers DO | None | None | None | None | - |
| Nicole Shonka MD | None | None | None | None | - |
| Dennis Shrieve MD, PhD | None | None | BrainLab | None | - |
| Allen Sills MD | Head Sense | National Football League | None | None | - |
| Jack Skinner PhD | None | None | None | None | - |
| Lode Swinnen MBChB | Abbott Laboratories Johns Hopkins University |
None | None | None | - |
| Christina Tsien MD | None | None | None | None | - |
| Stephanie Weiss MD | None | None | None | None | - |
| Patrick Wen MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. Immunocellulr Therapeutics Novartis Pharmaceuticals Corporation sanofi-aventis U.S. |
AbbVie, Inc. Cubist Foundation Medicine Genentech, Inc. Midatech Novartis Pharmaceuticals Corporation Novocure Vascular Biogenics |
Merck & Co., Inc. | None | - |
| Nicole Willmarth PhD | None | None | None | None | - |